These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

738 related articles for article (PubMed ID: 28871110)

  • 61. Analysis of heterogeneity of peritumoral T2 hyperintensity in patients with pretreatment glioblastoma: Prognostic value of MRI-based radiomics.
    Choi Y; Ahn KJ; Nam Y; Jang J; Shin NY; Choi HS; Jung SL; Kim BS
    Eur J Radiol; 2019 Nov; 120():108642. PubMed ID: 31546124
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Large-Scale Analysis Reveals Gene Signature for Survival Prediction in Primary Glioblastoma.
    Prasad B; Tian Y; Li X
    Mol Neurobiol; 2020 Dec; 57(12):5235-5246. PubMed ID: 32875483
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Radiomics in peritumoral non-enhancing regions: fractional anisotropy and cerebral blood volume improve prediction of local progression and overall survival in patients with glioblastoma.
    Kim JY; Yoon MJ; Park JE; Choi EJ; Lee J; Kim HS
    Neuroradiology; 2019 Nov; 61(11):1261-1272. PubMed ID: 31289886
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Survival prediction of patients suffering from glioblastoma based on two-branch DenseNet using multi-channel features.
    Fu X; Chen C; Li D
    Int J Comput Assist Radiol Surg; 2021 Feb; 16(2):207-217. PubMed ID: 33462763
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Radiomic MRI Phenotyping of Glioblastoma: Improving Survival Prediction.
    Bae S; Choi YS; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Lee SK
    Radiology; 2018 Dec; 289(3):797-806. PubMed ID: 30277442
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Robust performance of deep learning for distinguishing glioblastoma from single brain metastasis using radiomic features: model development and validation.
    Bae S; An C; Ahn SS; Kim H; Han K; Kim SW; Park JE; Kim HS; Lee SK
    Sci Rep; 2020 Jul; 10(1):12110. PubMed ID: 32694637
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Tumor grading of soft tissue sarcomas using MRI-based radiomics.
    Peeken JC; Spraker MB; Knebel C; Dapper H; Pfeiffer D; Devecka M; Thamer A; Shouman MA; Ott A; von Eisenhart-Rothe R; Nüsslin F; Mayr NA; Nyflot MJ; Combs SE
    EBioMedicine; 2019 Oct; 48():332-340. PubMed ID: 31522983
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Diffusion and perfusion MRI radiomics obtained from deep learning segmentation provides reproducible and comparable diagnostic model to human in post-treatment glioblastoma.
    Park JE; Ham S; Kim HS; Park SY; Yun J; Lee H; Choi SH; Kim N
    Eur Radiol; 2021 May; 31(5):3127-3137. PubMed ID: 33128598
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Effect of Heterogenous Subregions in Glioblastomas on Survival Stratification: A Radiomics Analysis Using the Multimodality MRI.
    Yin L; Liu Y; Zhang X; Lu H; Liu Y
    Technol Cancer Res Treat; 2021; 20():15330338211033059. PubMed ID: 34318731
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Radiomic Analysis Reveals Prognostic Information in T1-Weighted Baseline Magnetic Resonance Imaging in Patients With Glioblastoma.
    Ingrisch M; Schneider MJ; Nörenberg D; Negrao de Figueiredo G; Maier-Hein K; Suchorska B; Schüller U; Albert N; Brückmann H; Reiser M; Tonn JC; Ertl-Wagner B
    Invest Radiol; 2017 Jun; 52(6):360-366. PubMed ID: 28079702
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Novel Radiomic Features Based on Joint Intensity Matrices for Predicting Glioblastoma Patient Survival Time.
    Chaddad A; Daniel P; Desrosiers C; Toews M; Abdulkarim B
    IEEE J Biomed Health Inform; 2019 Mar; 23(2):795-804. PubMed ID: 29993848
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A radiomics-based model to differentiate glioblastoma from solitary brain metastases.
    Su CQ; Chen XT; Duan SF; Zhang JX; You YP; Lu SS; Hong XN
    Clin Radiol; 2021 Aug; 76(8):629.e11-629.e18. PubMed ID: 34092362
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Radiomics approach for survival prediction in chronic obstructive pulmonary disease.
    Cho YH; Seo JB; Lee SM; Kim N; Yun J; Hwang JE; Lee JS; Oh YM; Do Lee S; Loh LC; Ong CK
    Eur Radiol; 2021 Oct; 31(10):7316-7324. PubMed ID: 33847809
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A novel image signature-based radiomics method to achieve precise diagnosis and prognostic stratification of gliomas.
    Luo H; Zhuang Q; Wang Y; Abudumijiti A; Shi K; Rominger A; Chen H; Yang Z; Tran V; Wu G; Li Z; Fan Z; Qi Z; Guo Y; Yu J; Shi Z
    Lab Invest; 2021 Apr; 101(4):450-462. PubMed ID: 32829381
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A risk signature with four autophagy-related genes for predicting survival of glioblastoma multiforme.
    Wang Y; Zhao W; Xiao Z; Guan G; Liu X; Zhuang M
    J Cell Mol Med; 2020 Apr; 24(7):3807-3821. PubMed ID: 32065482
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Non-invasive genotype prediction of chromosome 1p/19q co-deletion by development and validation of an MRI-based radiomics signature in lower-grade gliomas.
    Han Y; Xie Z; Zang Y; Zhang S; Gu D; Zhou M; Gevaert O; Wei J; Li C; Chen H; Du J; Liu Z; Dong D; Tian J; Zhou D
    J Neurooncol; 2018 Nov; 140(2):297-306. PubMed ID: 30097822
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Multi-center study finds postoperative residual non-enhancing component of glioblastoma as a new determinant of patient outcome.
    Kotrotsou A; Elakkad A; Sun J; Thomas GA; Yang D; Abrol S; Wei W; Weinberg JS; Bakhtiari AS; Kircher MF; Luedi MM; de Groot JF; Sawaya R; Kumar AJ; Zinn PO; Colen RR
    J Neurooncol; 2018 Aug; 139(1):125-133. PubMed ID: 29619649
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Computer-extracted MR imaging features are associated with survival in glioblastoma patients.
    Mazurowski MA; Zhang J; Peters KB; Hobbs H
    J Neurooncol; 2014 Dec; 120(3):483-8. PubMed ID: 25151504
    [TBL] [Abstract][Full Text] [Related]  

  • 79. MR-based radiomics signature in differentiating ocular adnexal lymphoma from idiopathic orbital inflammation.
    Guo J; Liu Z; Shen C; Li Z; Yan F; Tian J; Xian J
    Eur Radiol; 2018 Sep; 28(9):3872-3881. PubMed ID: 29632999
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Sub-region based radiomics analysis for survival prediction in oesophageal tumours treated by definitive concurrent chemoradiotherapy.
    Xie C; Yang P; Zhang X; Xu L; Wang X; Li X; Zhang L; Xie R; Yang L; Jing Z; Zhang H; Ding L; Kuang Y; Niu T; Wu S
    EBioMedicine; 2019 Jun; 44():289-297. PubMed ID: 31129097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.